Neuroprotective effects of resveratrol against traumatic brain injury in immature rats

Ulker Sönmez1, Ataç Sönmez, Güven Erbil

  • 1Department of Histology and Embryology, School of Medicine, Dokuz Eylul University Inciralti, TR-35340 Izmir, Turkey. atac.sonmez@deu.edu.tr

Insights

Resveratrol treatment significantly reduced brain damage and improved memory in young rats after traumatic brain injury (TBI). This finding highlights resveratrol's neuroprotective potential for TBI recovery in developing brains.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Pediatric Traumatology

Background:

  • Traumatic brain injury (TBI) in childhood, from accidents or abuse, is a leading cause of mortality and long-term disability.
  • Current TBI management is primarily supportive due to a lack of specific pharmacological treatments for secondary injury progression.

Purpose of the Study:

  • To investigate the neuroprotective effects of resveratrol on hippocampal damage and behavioral deficits in young rats following contusion injury.
  • To evaluate resveratrol's potential to mitigate secondary injury mechanisms in pediatric TBI models.

Main Methods:

  • A single intraperitoneal dose of resveratrol (100 mg/kg) was administered to 7-day-old rat pups immediately after inducing a contusion injury.
  • Hippocampal neuron loss was assessed using cresyl violet staining.
  • Behavioral alterations, including anxiety and memory, were evaluated using open field and novel object recognition tests two weeks post-trauma.

Main Results:

  • Resveratrol treatment significantly reduced neuronal loss in both ipsilateral and contralateral hippocampal regions following TBI.
  • Animals treated with resveratrol exhibited decreased anxiety levels.
  • Cognitive function, specifically cortex/hippocampus-dependent memory, was enhanced in resveratrol-treated rats compared to controls.

Conclusions:

  • Acute resveratrol administration demonstrates significant neuroprotective effects against trauma-induced hippocampal neuron loss.
  • Resveratrol treatment ameliorates cognitive impairments associated with blunt head trauma in a developing rat model.
  • These findings suggest resveratrol as a potential therapeutic agent for mitigating secondary injury and cognitive deficits in pediatric TBI.

Related Concept Videos